标普和纳斯达克内在价值 联系我们

Harpoon Therapeutics, Inc. HARP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$700.00
+2942.2%

共有 50 笔近期内部人交易记录记录,涉及 Harpoon Therapeutics, Inc. (HARP), 包括 36 笔买入12 笔卖出. 内部人买入总额为 $494.5M 内部人卖出总额为 $2.38M.

近期活跃的重要内部人包括 Merck & Co., Inc., Bailes Joseph S, Silvernail Lauren P. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — HARP

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2024-03-11 Merck & Co., Inc. 10 Percent Owner 知情买入 21,397,205 $23.00 $492.14M 1,000
2024-03-11 Bailes Joseph S Director 股份退回 2,300 $6.66 $15.31K -
2024-03-11 Silvernail Lauren P Director 股份退回 2,300 $6.66 $15.31K -
2024-03-11 Hunt Ronald 10 Percent Owner 股份退回 2,300 $6.66 $15.31K -
2024-03-11 Myers Scott Dunseth Director 股份退回 4,600 $6.66 $30.62K -
2024-03-11 Eastland Julia Marie President and CEO 股份退回 40,759 $8.90 $362.76K -
2024-03-11 Drachman Jonathan G Director 股份退回 2,300 $6.66 $15.31K -
2024-03-11 Robbins Andrew R Director 股份退回 2,300 $6.66 $15.31K -
2024-03-11 Lanza Frank J Principal Fin. & Acctng Ofc. 股份退回 8,643 $6.97 $60.24K -
2024-03-11 Bucher James B Chief Legal Officer 股份退回 110,000 $11.30 $1.24M -
2024-03-11 Walker Luke Nathaniel Chief Medical Officer 股份退回 10,000 $8.90 $89K -
2024-03-11 Chin Mark Director 股份退回 2,300 $6.66 $15.31K -
2024-03-11 New Leaf Biopharma Opportunities Ii, L.p. 10 Percent Owner 股份退回 85,750 $5.83 $500.31K -
2024-03-08 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 424 - - 13,224
2024-03-08 Drachman Jonathan G Director 限制性股票授予 (RSU) 415 - - 5,415
2024-03-08 Chin Mark Director 限制性股票授予 (RSU) 424 - - 13,224
2024-01-07 Eastland Julia Marie President and CEO 限制性股票授予 (RSU) 178,500 - - 232,003
2024-01-07 Lanza Frank J Principal Fin. & Acctng Ofc. 限制性股票授予 (RSU) 15,000 - - 18,362
2024-01-07 Walker Luke Nathaniel Chief Medical Officer 限制性股票授予 (RSU) 115,000 - - 135,000
2024-01-07 Merck & Co., Inc. 10 Percent Owner 未知 - - - -
2024-01-01 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 1,072 - - 12,801
2024-01-01 Myers Scott Dunseth Director 限制性股票授予 (RSU) 2,048 - - 22,666
2024-01-01 Chin Mark Director 限制性股票授予 (RSU) 1,072 - - 12,801
2023-12-21 Bucher James B Officer 未知 - - - -
2023-12-21 Bucher James B Chief Legal Officer 限制性股票授予 (RSU) 110,000 $11.30 $1.24M 110,000
2023-11-27 Bailes Joseph S Director 限制性股票授予 (RSU) 5,000 - - 5,000
2023-11-27 Silvernail Lauren P Director 限制性股票授予 (RSU) 5,000 - - 5,000
2023-11-27 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 5,000 - - 11,729
2023-11-27 Myers Scott Dunseth Director 限制性股票授予 (RSU) 5,000 - - 20,618
2023-11-27 Drachman Jonathan G Director 限制性股票授予 (RSU) 5,000 - - 5,000
2023-11-27 Robbins Andrew R Director 限制性股票授予 (RSU) 5,000 - - 5,000
2023-11-27 Chin Mark Director 限制性股票授予 (RSU) 5,000 - - 11,729
2023-11-26 Eastland Julia Marie President and CEO 限制性股票授予 (RSU) 50,000 - - 53,503
2023-11-26 Lanza Frank J Principal Fin. & Acctng Ofc. 限制性股票授予 (RSU) 2,000 - - 3,362
2023-11-26 Walker Luke Nathaniel Chief Medical Officer 限制性股票授予 (RSU) 20,000 - - 20,000
2023-10-25 Hunt Ronald 10 Percent Owner 知情买入 85,750 $5.83 $500.31K 85,750
2023-10-25 New Leaf Biopharma Opportunities Ii, L.p. 10 Percent Owner 知情买入 85,750 $5.83 $500.31K 85,750
2023-10-01 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 3,035 - - 6,729
2023-10-01 Myers Scott Dunseth Director 限制性股票授予 (RSU) 5,797 - - 15,618
2023-10-01 Chin Mark Director 限制性股票授予 (RSU) 3,035 - - 6,729
2023-07-01 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 18,656 - - 36,941
2023-07-01 Myers Scott Dunseth Director 限制性股票授予 (RSU) 35,634 - - 98,215
2023-07-01 Chin Mark Director 限制性股票授予 (RSU) 18,656 - - 36,941
2023-06-22 Bailes Joseph S Director 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
2023-06-22 Silvernail Lauren P Director 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
2023-06-22 Hunt Ronald 10 Percent Owner 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
2023-06-22 Myers Scott Dunseth Director 限制性股票授予 (RSU) 46,000 $0.67 $30.62K 46,000
2023-06-22 Drachman Jonathan G Director 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
2023-06-22 Robbins Andrew R Director 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
2023-06-22 Chin Mark Director 限制性股票授予 (RSU) 23,000 $0.67 $15.31K 23,000
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言